5D7-32172-35692
4 vaccinations
7 coded responses
49 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 970 / OR
- Registered
- 2021-02-16
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-02-16
Registered in v-safe
-
2021-02-16
Dose 1 — Moderna
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, NauseaAdult check-in
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-03-02
Survey response — day 14, dose 1MedDRA: Back pain, Injection site erythema, Injection site swelling, Injection site warmth — Feeling: Good · Be unable to do your normal daily activitiesFree text: red itchy swollen and hot at the injection site- started on the evening of day 7 and lasted about 24 hours. In addition had back pain starting on day 6 and lasting for 3 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
-
2021-03-16
Dose 2 — Moderna
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Headache, Muscle or body achesAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
-
2021-03-31
Survey response — day 14, dose 2MedDRA: Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle pain in backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-06-15
- 2021-09-14
-
2021-10-24
Dose 3 — Moderna
- 2021-10-26
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-08
- 2021-11-14
- 2021-11-28
- 2021-12-05
- 2022-01-23
-
2022-04-14
Dose 4 — Moderna
-
2022-04-14
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2022-04-16
-
2022-04-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-04-18
- 2022-04-20
- 2022-04-21
- 2022-04-28
-
2022-05-08
Survey response — day 21, dose 4MedDRA: Ear congestion, Eye disorder, Headache, Respiratory tract congestion, Upper respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache-upper respiratory congestion including eyes and ears, slight chest congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Survey response — day 28, dose 4MedDRA: Cough, Headache, Malaise, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache fever runny nose sore throat chest congestion general feeling of unwellness coughMedDRA releases: 2024-11 · check-in free text available
-
2022-05-22
Survey response — day 35, dose 4MedDRA: Eye pruritus, Fatigue, Headache, Lacrimation increased, Oropharyngeal pain, Pain, Respiratory tract congestion, Sinus pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stuffy head headache sore throat itchy watery eyes sinus pain fatigue bodyachesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-29
Survey response — day 42, dose 4MedDRA: Cough, Muscle spasms, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Digestive- cramps- increased coughingMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Survey response — 3 months, dose 4MedDRA: COVID-19, Fatigue, Gastrointestinal disorder, Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Digestive issues, headaches for about three weeks after recovering from covid- and extreme exhaustion on occasion.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Moderna | |
| 2 | 2021-03-16 | Moderna | |
| 3 | 2021-10-24 | Moderna | No |
| 4 | 2022-04-14 | Moderna | No |
Free text
Release 4 — day 14, dose 1
Symptoms: red itchy swollen and hot at the injection site- started on the evening of day 7 and lasted about 24 hours. In addition had back pain starting on day 6 and lasting for 3 days.
Release 6 — day 14, dose 2
Symptoms: Muscle pain in back
Release 11 — day 21, dose 4
Symptoms: Headache-upper respiratory congestion including eyes and ears, slight chest congestion
Release 11 — day 28, dose 4
Symptoms: Headache fever runny nose sore throat chest congestion general feeling of unwellness cough
Release 11 — day 35, dose 4
Symptoms: Stuffy head headache sore throat itchy watery eyes sinus pain fatigue bodyaches
Release 11 — day 42, dose 4
Symptoms: Digestive- cramps- increased coughing
Release 12 — 3 months, dose 4
Symptoms: Digestive issues, headaches for about three weeks after recovering from covid- and extreme exhaustion on occasion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear congestion | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release